Literature DB >> 19012750

Altered hippocampal long-term synaptic plasticity in mice deficient in the PGE2 EP2 receptor.

Hongwei Yang1, Jian Zhang, Richard M Breyer, Chu Chen.   

Abstract

Our laboratory demonstrated previously that PGE2-induced modulation of hippocampal synaptic transmission is via a pre-synaptic PGE2 EP2 receptor. However, little is known about whether the EP2 receptor is involved in hippocampal long-term synaptic plasticity and cognitive function. Here we show that long-term potentiation at the hippocampal perforant path synapses was impaired in mice deficient in the EP2 (KO), while membrane excitability and passive properties in granule neurons were normal. Importantly, escape latency in the water maze in EP2 KO was longer than that in age-matched EP2 wild-type littermates (WT). We also observed that long-term potentiation was potentiated in EP2 WT animals that received lipopolysaccharide (LPS, i.p.), but not in EP2 KO. Bath application of PGE2 or butaprost, an EP2 receptor agonist, increased synaptic transmission and decreased paired-pulses ratio in EP2 WT mice, but failed to induce the changes in EP2 KO mice. Meanwhile, synaptic transmission was elevated by application of forskolin, an adenylyl cyclase activator, both in EP2 KO and WT animals. In addition, the PGE2-enhanced synaptic transmission was significantly attenuated by application of PKA, IP3 or MAPK inhibitors in EP2 WT animals. Our results show that hippocampal long-term synaptic plasticity is impaired in mice deficient in the EP2, suggesting that PGE2-EP2 signaling is important for hippocampal long-term synaptic plasticity and cognitive function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19012750      PMCID: PMC2605769          DOI: 10.1111/j.1471-4159.2008.05766.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  40 in total

1.  Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor.

Authors:  C R Kennedy; Y Zhang; S Brandon; Y Guan; K Coffee; C D Funk; M A Magnuson; J A Oates; M D Breyer; R M Breyer
Journal:  Nat Med       Date:  1999-02       Impact factor: 53.440

Review 2.  Prostanoid receptors: structures, properties, and functions.

Authors:  S Narumiya; Y Sugimoto; F Ushikubi
Journal:  Physiol Rev       Date:  1999-10       Impact factor: 37.312

3.  Heterogeneous expression and regulation of hippocampal prostaglandin E2 receptors.

Authors:  Peimin Zhu; Ali Genc; Xiong Zhang; Jian Zhang; Nicolas G Bazan; Chu Chen
Journal:  J Neurosci Res       Date:  2005-09-15       Impact factor: 4.164

4.  Postsynaptically synthesized prostaglandin E2 (PGE2) modulates hippocampal synaptic transmission via a presynaptic PGE2 EP2 receptor.

Authors:  Nan Sang; Jian Zhang; Victor Marcheselli; Nicolas G Bazan; Chu Chen
Journal:  J Neurosci       Date:  2005-10-26       Impact factor: 6.167

5.  Endogenous PGE2 regulates membrane excitability and synaptic transmission in hippocampal CA1 pyramidal neurons.

Authors:  Chu Chen; Nicolas G Bazan
Journal:  J Neurophysiol       Date:  2005-02       Impact factor: 2.714

6.  Post-training intrahippocampal infusion of the COX-2 inhibitor celecoxib impaired spatial memory retention in rats.

Authors:  Mohammad Sharifzadeh; Nasser Naghdi; Sara Khosrovani; Seyed Nasser Ostad; Kurdistan Sharifzadeh; Ali Roghani
Journal:  Eur J Pharmacol       Date:  2005-03-28       Impact factor: 4.432

7.  Endocannabinoids restrict hippocampal long-term potentiation via CB1.

Authors:  Kristen A Slanina; Marisa Roberto; Paul Schweitzer
Journal:  Neuropharmacology       Date:  2005-10       Impact factor: 5.250

8.  Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampus.

Authors:  Kristen A Slanina; Paul Schweitzer
Journal:  Neuropharmacology       Date:  2005-10       Impact factor: 5.250

Review 9.  Lipid signaling and synaptic plasticity.

Authors:  Nan Sang; Chu Chen
Journal:  Neuroscientist       Date:  2006-10       Impact factor: 7.519

10.  Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes.

Authors:  Y Boie; R Stocco; N Sawyer; D M Slipetz; M D Ungrin; F Neuschäfer-Rube; G P Püschel; K M Metters; M Abramovitz
Journal:  Eur J Pharmacol       Date:  1997-12-11       Impact factor: 4.432

View more
  32 in total

1.  Synaptic and extrasynaptic NMDA receptors differentially modulate neuronal cyclooxygenase-2 function, lipid peroxidation, and neuroprotection.

Authors:  David T Stark; Nicolas G Bazan
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

Review 2.  Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus.

Authors:  Yifeng Du; Timothy Kemper; Jiange Qiu; Jianxiong Jiang
Journal:  Expert Rev Neurother       Date:  2016-01-13       Impact factor: 4.618

3.  Neuroprotective role of prostaglandin PGE2 EP2 receptor in hemin-mediated toxicity.

Authors:  Shekher Mohan; Shuh Narumiya; Sylvain Doré
Journal:  Neurotoxicology       Date:  2014-11-13       Impact factor: 4.294

4.  Suppressing pro-inflammatory prostaglandin signaling attenuates excitotoxicity-associated neuronal inflammation and injury.

Authors:  Jianxiong Jiang; Ying Yu; Erika Reime Kinjo; Yifeng Du; Hoang Phuong Nguyen; Ray Dingledine
Journal:  Neuropharmacology       Date:  2019-02-11       Impact factor: 5.250

5.  PGE2 signaling via the neuronal EP2 receptor increases injury in a model of cerebral ischemia.

Authors:  Qingkun Liu; Xibin Liang; Qian Wang; Edward N Wilson; Rachel Lam; Jing Wang; William Kong; Connie Tsai; Tingting Pan; Paul B Larkin; Mehrdad Shamloo; Katrin I Andreasson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-29       Impact factor: 11.205

Review 6.  Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection.

Authors:  Jianxiong Jiang; Ray Dingledine
Journal:  Trends Pharmacol Sci       Date:  2013-06-21       Impact factor: 14.819

7.  Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor.

Authors:  Jianxiong Jiang; Thota Ganesh; Yuhong Du; Pahk Thepchatri; Asheebo Rojas; Iestyn Lewis; Serdar Kurtkaya; Lian Li; Min Qui; Geidy Serrano; Renee Shaw; Aiming Sun; Ray Dingledine
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-14       Impact factor: 11.205

8.  Inhibiting the PGE2 Receptor EP2 Mitigates Excitotoxicity and Ischemic Injury.

Authors:  Lexiao Li; Ying Yu; Ruida Hou; Jiukuan Hao; Jianxiong Jiang
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-25

9.  Prostaglandin E2 EP1 receptor antagonist improves motor deficits and rescues memory decline in R6/1 mouse model of Huntington's disease.

Authors:  Marta Anglada-Huguet; Xavier Xifró; Albert Giralt; Alfonsa Zamora-Moratalla; Eduardo D Martín; Jordi Alberch
Journal:  Mol Neurobiol       Date:  2013-11-07       Impact factor: 5.590

10.  Prostaglandin E2-induced masculinization of brain and behavior requires protein kinase A, AMPA/kainate, and metabotropic glutamate receptor signaling.

Authors:  Christopher L Wright; Margaret M McCarthy
Journal:  J Neurosci       Date:  2009-10-21       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.